Therapeutic Expertise: Oncology
Increased life expectancy, lifestyle changes, and migration to urban areas with better access to healthcare has helped the diagnosis and
treatment of cancer in India to increase significantly. According to the American Cancer Society, there are approximately 2.5 million patients
currently suffering from a form of cancer in India, and approximately 800,000 cases were diagnosed in 2000. More than 70% of India’s cancer
patients receive late diagnoses, when symptoms are advanced and treatment is less effective. With the number of cases steadily increasing,
physicians are working to find alternative treatments and a cure for the various forms of cancer prevalent in India.
Patient Access
India’s extensive disease and treatment-naïve populations coupled with our network of research sites provide substantial patient access for FDA- regulated global trials. ISS is affiliated with more than 125 oncologists looking to conduct additional clinical trials for oncology and cancer-related indications. Our oncologists treat an average of 500 cases per month, with a steady increase of new patients. |
|
Oncology Experience
Adenocarcinoma
|
I |
18 |
On-time |
95% |
Breast Carcinoma |
II |
22 |
On-time |
92% |
Pancreatic Carcinoma |
III |
16 |
Ahead of Schedule |
97% |
Head & Neck Carcinoma |
II |
26 |
Ahead of Schedule |
89% |
Small Cell Lung Cancer |
III |
24 |
Ongoing |
100% |
Metastatic Breast Cancer |
II |
2/35 within 1 week |
Ongoing |
100% |
Recurrent Head and Neck Cancer |
I / III |
100 pts / 7 sites |
TBD Initiating |
TBD Initiating |
Multiple Indications (G-CSF support therapy) |
III |
100 |
On-time |
94% |
Multiple Indications (Gm- CSF support therapy) |
III |
100 |
On-time |
96% |
|